Literature DB >> 665172

On receptors for estrogens (E2) and androgens (DHT) in human endometrial carcinoma and ovarian tumours.

L G Friberg, S Kullander, J P Persijn, C B Korsten.   

Abstract

Some human endometrial carcinomas contain receptors for estrogen (E2) and dihydrotestosterone (DHT). Analysis of 50 primary endometrial carcinomas by agar gel electrophoresis revealed a varying receptor pattern, absence of both receptors, sole presence of E2- or DHT- receptor, or presence of both. Highly differentiated tumours often had receptors of both types (7/18) and poorly differentiated tumours most often lacked them (1/10). Primary tumours with metastases (Stages III-IV) seldom had combined receptors, only in 2 cases out of 9. Growth of the tumour down in the cervical canal (Stage II) implied absence of combined receptors in all of the 13 cases studied. In 8 different ovarian tumours, presence of either E2- or DHT-receptors was found in 6. The findings are discussed in relation to hormonal treatment of the disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 665172     DOI: 10.3109/00016347809154895

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  4 in total

1.  Expression of estradiol and progesterone receptors by histologically normal endometria of women with postmenopausal bleeding.

Authors:  G I Gorodeski; C M Bahary
Journal:  J Endocrinol Invest       Date:  1991 Jul-Aug       Impact factor: 4.256

2.  Effect of progestins, androgens, estrogens and antiestrogens on 3H-thymidine uptake by human endometrial and endosalpinx cells in vitro.

Authors:  J Neulen; B Wagner; M Runge; M Breckwoldt
Journal:  Arch Gynecol       Date:  1987

3.  Multiple steroid hormone receptors in normal and abnormal human endometrium.

Authors:  G Prodi; G Nicoletti; C De Giovanni; M C Galli; S Grilli; P Nanni; G Gola; R Rocchetta; C Orlandi
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

4.  Dietary factors and epithelial ovarian cancer.

Authors:  X O Shu; Y T Gao; J M Yuan; R G Ziegler; L A Brinton
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.